Dr. Fred Moll and Vitestro CEO Toon Overbeeke Sonder Capital co-led the $22 million investment in Vitestro to ramp up production and commercialization. UTRECHT, The Netherlands, April 30, 2024 (GLOBE ...

Vitestro has raised $70m to advance development and broaden the commercialisation of its autonomous blood-drawing robot. The Dutch company’s oversubscribed Series B financing round saw a mix of ...

– Vitestro, the pioneering autonomous blood drawing company, today announced that it has raised $22 million (€20 million) funding to accelerate commercialization of its innovative robotic blood ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The FDA has authorized Vitestro's Aletta system, the first standalone robotic device for ...

Utrecht-based Vitestro has raised €20mn to bring its robotic blood drawing device to market. Founded in 2017, Vitestro aims to improve the blood draw experience for patients and address personnel ...

UTRECHT, The Netherlands, Sept. 6, 2023 /PRNewswire/ -- Vitestro, expert in medical robotics, has launched the A.D.O.P.T. Trial for its autonomous blood drawing device (image). With an anticipated ...

Maxine Moor, VP of Commercial Europe "Vitestro has been interacting with clinical labs throughout Europe for the past years. They confirmed the huge need for phlebotomy automation and couldn't wait ...

Add Yahoo as a preferred source to see more of our stories on Google. The traditional process of drawing blood may soon get a high-tech upgrade as health systems across the US begin testing a robot ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The FDA has authorized Aletta, a robotic device designed for autonomous blood draws that ...

CHICAGO — The practice of drawing blood has changed very little over the decades. It looks about the same now as it did 50 years ago. That process, however, may be about to get a modern makeover.